SlideShare ist ein Scribd-Unternehmen logo
1 von 94
Bioavailability  Of  Disperse Dosage Forms By Mohammad Sohail Mphil pharmaceutics Islamia university Bahawalpur [email_address]
Bioavailability Of Disperse Dosage Forms ,[object Object],[object Object],[object Object],[object Object],[object Object]
Relative Bioavailability ,[object Object],[object Object]
RBA ,[object Object],[object Object],[object Object],[object Object],[object Object]
Absolute Bioabavailability ,[object Object],[object Object],[object Object]
Absolute Bioavailability ,[object Object],[object Object],[object Object],[object Object]
Difference between Absolute and Relative  Bioavailability ,[object Object],[object Object],[object Object],[object Object],[object Object]
AB vs RBA   Drug Product AUC ( mcg/ml . hr ) A  IV Injection 100 B  Oral dosage form (Refer) 50 C  Oral dosage form (generic) 40
Bioequivalent Drug Products ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Disperse Systems ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Routes Of Drug Administration ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Properties Of Disperse Dosage Form ,[object Object],[object Object],[object Object],[object Object]
Properties Of Disperse Dosage Form ,[object Object],[object Object],[object Object],[object Object]
Advantages Of Disperse Dosage Form ,[object Object],[object Object],[object Object],[object Object]
Formulation Factors Affecting Drug Release  From Disperse Systems : ,[object Object],[object Object],[object Object],[object Object],[object Object]
Wetting ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Particle Size ,[object Object],[object Object],[object Object],[object Object]
Particle Size ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Viscosity ,[object Object],[object Object],[object Object],[object Object]
Viscosity ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Drug release from disperse systems ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Absorption Barriers   ,[object Object],[object Object]
Barriers for Skin
Barriers For Skin ,[object Object],[object Object],[object Object],[object Object]
pathways for percutaneous absorption: ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Barriers For Eye
Barriers For Eye ,[object Object],[object Object],[object Object]
Barriers For Eye ,[object Object],[object Object],[object Object]
Barriers For GIT
Barriers For GIT ,[object Object],[object Object],[object Object],[object Object]
Barriers for GIT ,[object Object],[object Object]
Barrier for Pulmonary Drug Delivery   ,[object Object],[object Object],[object Object],[object Object]
Barriers for Pulmonary Drug Delivery ,[object Object],[object Object],[object Object]
Absorption Factors SKIN EYE GIT Barrier Stratum corneum Superficial layer of epithelium  Epithelium  Thickness  8-26 layers  5-6 layers  1 layer hydration 10-25% 78% High area 2-25cm 2 1.3cm 2 2,000,000
Physiological Factors Affecting Absorption ,[object Object],[object Object],[object Object],[object Object],[object Object]
Factors affecting Percutaneous Absorption ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Factors affecting Percutaneous Absorption ,[object Object],[object Object],[object Object],[object Object]
Factors affecting Percutaneous Absorption ,[object Object],[object Object],[object Object],[object Object]
Percutaneous Absorption ,[object Object],[object Object],[object Object],[object Object],[object Object]
Percutaneous Absorption ,[object Object],[object Object],[object Object]
Factors affecting Ophthalmic Absorption ,[object Object],[object Object],[object Object],[object Object],[object Object]
Factors affecting Ophthalmic Absorption ,[object Object],[object Object],[object Object]
Factors affecting G.I.T Absorption ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Factors affecting G.I.T Absorption ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
pH Location pH Stomach Duodenum Jejunum Ileum Colon Rectum 1.5-3.5 5-7 6-7 6.0-7.5 5.5-7.0 7
pH ,[object Object],[object Object]
Metabolism ,[object Object],[object Object],[object Object],[object Object],[object Object]
Metabolism ,[object Object],[object Object],[object Object],[object Object]
Metabolism ,[object Object],[object Object]
Presence Of Food ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Presence Of Food ,[object Object],[object Object]
Individual variation ,[object Object],[object Object],[object Object],[object Object]
Gender ,[object Object],[object Object]
Race ,[object Object],[object Object],[object Object]
Example ,[object Object],[object Object],[object Object],[object Object]
Age ,[object Object],[object Object],[object Object]
Methods Of Assessing Bioavailability Of Drugs ,[object Object],[object Object]
Methods Of Assessing Bioavailability Of Drugs ,[object Object],[object Object],[object Object],[object Object],[object Object]
Plasma Drug Concentration ,[object Object],[object Object],[object Object]
Plasma concentration vs. time profile of a single dose of a drug ingested orally Plasma Concentration
Key Parameters: ,[object Object],[object Object],[object Object],[object Object],[object Object]
AUC
Peak height or C max ,[object Object],[object Object],[object Object]
Time of occurrence or t max ,[object Object],[object Object],[object Object]
(2) Urinary Drug excretion Data ,[object Object],[object Object],[object Object]
Urinary Drug excretion
(3)   Acute pharmacodynamic or pharmacologic effect ,[object Object],[object Object],[object Object]
Acute pharmacodynamic or pharmacologic effect ,[object Object],[object Object],[object Object]
Acute pharmacodynamic or pharmacologic effect
(4)   Clinical Observations ,[object Object],[object Object],[object Object]
(5)   In vitro Bioavailability studies ,[object Object],[object Object],[object Object],[object Object]
Gastrointestinal Bioavailability ,[object Object],[object Object],[object Object]
Gastrointestinal Bioavailability Oral suspension ,[object Object],[object Object],[object Object]
Oral suspension ,[object Object],[object Object]
Oral suspension ,[object Object],[object Object],[object Object],[object Object]
Oral suspension ,[object Object],[object Object],[object Object]
Oral suspension ,[object Object],[object Object]
Oral emulsion ,[object Object],[object Object],[object Object],[object Object],[object Object]
Dermatological Bioavailability ,[object Object],[object Object],[object Object],[object Object],[object Object]
Dermatological Bioavailability ,[object Object],[object Object],[object Object]
Dermatological Bioavailability ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Dermatological Bioavailability ,[object Object],[object Object],[object Object],[object Object],[object Object]
Measurement of Dermatological bioavailability ,[object Object],[object Object],[object Object],[object Object]
Procedure:  ,[object Object],[object Object],[object Object]
Ophthalmic Bioavailability ,[object Object],[object Object],[object Object]
Ophthalmic suspensions :   ,[object Object],[object Object],[object Object]
Ophthalmic suspensions :   ,[object Object],[object Object]
Ophthalmic suspensions : ,[object Object],[object Object],[object Object]
Ophthalmic ointments : ,[object Object],[object Object]
Ophthalmic ointments : ,[object Object],[object Object],[object Object]
Ophthalmic ointments : ,[object Object]
Rectal bioavailability : ,[object Object],[object Object],[object Object]
Rectal suppositories : ,[object Object],[object Object],[object Object],[object Object]
Rectal suppositories : ,[object Object],[object Object]

Weitere ähnliche Inhalte

Was ist angesagt?

FORMULATION FACTORS EFFECTING BIOAVAILABILITY OF DRUGS
FORMULATION FACTORS EFFECTING BIOAVAILABILITY OF DRUGSFORMULATION FACTORS EFFECTING BIOAVAILABILITY OF DRUGS
FORMULATION FACTORS EFFECTING BIOAVAILABILITY OF DRUGSN Anusha
 
Pharmacokinetics / Biopharmaceutics - drug absorption
Pharmacokinetics / Biopharmaceutics - drug absorptionPharmacokinetics / Biopharmaceutics - drug absorption
Pharmacokinetics / Biopharmaceutics - drug absorptionAreej Abu Hanieh
 
TRANSDERMAL DRUG DELIVERY SYSTEM
TRANSDERMAL DRUG DELIVERY SYSTEMTRANSDERMAL DRUG DELIVERY SYSTEM
TRANSDERMAL DRUG DELIVERY SYSTEMDr Gajanan Sanap
 
Modified release drug products
Modified release drug productsModified release drug products
Modified release drug productsSOM NATH PRASAD
 
Consolidation seminar......
Consolidation seminar......Consolidation seminar......
Consolidation seminar......Akshata shettar
 
Tablet compression student (2)
Tablet compression student (2)Tablet compression student (2)
Tablet compression student (2)mizan00
 
Rate limiting steps in drug absorption
Rate limiting steps in drug absorptionRate limiting steps in drug absorption
Rate limiting steps in drug absorptionC Prakash
 
Rate limiting steps in drug absorption [autosaved]
Rate limiting steps in drug absorption [autosaved]Rate limiting steps in drug absorption [autosaved]
Rate limiting steps in drug absorption [autosaved]Nagaraju Ravouru
 
Physics of tablet compression
Physics of tablet compressionPhysics of tablet compression
Physics of tablet compressionMahadev Birajdar
 
Pulmonary drug delivery system [PDDS]
Pulmonary drug delivery system [PDDS]Pulmonary drug delivery system [PDDS]
Pulmonary drug delivery system [PDDS]Sagar Savale
 
Compression and compaction
Compression and compactionCompression and compaction
Compression and compactionSagar Savale
 
Liquid dosage form
Liquid dosage form Liquid dosage form
Liquid dosage form ROHIT YADAV
 
pH partition theory of drug absorption
pH partition theory of drug absorptionpH partition theory of drug absorption
pH partition theory of drug absorptionAravinda Palyam
 
Propellants
PropellantsPropellants
Propellantspharmacy
 
Pharmaceutical suspension
Pharmaceutical suspensionPharmaceutical suspension
Pharmaceutical suspensionkaleab taye
 
Pulmonary drug delivery system.
Pulmonary drug delivery system.Pulmonary drug delivery system.
Pulmonary drug delivery system.Mohammad Imran
 
Evaluation of capules
Evaluation of capulesEvaluation of capules
Evaluation of capulesShaik Sana
 

Was ist angesagt? (20)

Dissolution methods
Dissolution methodsDissolution methods
Dissolution methods
 
FORMULATION FACTORS EFFECTING BIOAVAILABILITY OF DRUGS
FORMULATION FACTORS EFFECTING BIOAVAILABILITY OF DRUGSFORMULATION FACTORS EFFECTING BIOAVAILABILITY OF DRUGS
FORMULATION FACTORS EFFECTING BIOAVAILABILITY OF DRUGS
 
Pharmacokinetics / Biopharmaceutics - drug absorption
Pharmacokinetics / Biopharmaceutics - drug absorptionPharmacokinetics / Biopharmaceutics - drug absorption
Pharmacokinetics / Biopharmaceutics - drug absorption
 
TRANSDERMAL DRUG DELIVERY SYSTEM
TRANSDERMAL DRUG DELIVERY SYSTEMTRANSDERMAL DRUG DELIVERY SYSTEM
TRANSDERMAL DRUG DELIVERY SYSTEM
 
Modified release drug products
Modified release drug productsModified release drug products
Modified release drug products
 
Consolidation seminar......
Consolidation seminar......Consolidation seminar......
Consolidation seminar......
 
Tablet compression student (2)
Tablet compression student (2)Tablet compression student (2)
Tablet compression student (2)
 
Rate limiting steps in drug absorption
Rate limiting steps in drug absorptionRate limiting steps in drug absorption
Rate limiting steps in drug absorption
 
Rate limiting steps in drug absorption [autosaved]
Rate limiting steps in drug absorption [autosaved]Rate limiting steps in drug absorption [autosaved]
Rate limiting steps in drug absorption [autosaved]
 
Dissolution and solubility
Dissolution and solubilityDissolution and solubility
Dissolution and solubility
 
Physics of tablet compression
Physics of tablet compressionPhysics of tablet compression
Physics of tablet compression
 
Pulmonary drug delivery system [PDDS]
Pulmonary drug delivery system [PDDS]Pulmonary drug delivery system [PDDS]
Pulmonary drug delivery system [PDDS]
 
Compression and compaction
Compression and compactionCompression and compaction
Compression and compaction
 
Liquid dosage form
Liquid dosage form Liquid dosage form
Liquid dosage form
 
pH partition theory of drug absorption
pH partition theory of drug absorptionpH partition theory of drug absorption
pH partition theory of drug absorption
 
IVIVC
IVIVCIVIVC
IVIVC
 
Propellants
PropellantsPropellants
Propellants
 
Pharmaceutical suspension
Pharmaceutical suspensionPharmaceutical suspension
Pharmaceutical suspension
 
Pulmonary drug delivery system.
Pulmonary drug delivery system.Pulmonary drug delivery system.
Pulmonary drug delivery system.
 
Evaluation of capules
Evaluation of capulesEvaluation of capules
Evaluation of capules
 

Ähnlich wie Bioavailability Of Disperse Dosage Form

Diffusion finals, feb 29, 2012
Diffusion finals, feb 29, 2012Diffusion finals, feb 29, 2012
Diffusion finals, feb 29, 2012eckotanglao
 
Buccal drug delivery systems
Buccal drug delivery systemsBuccal drug delivery systems
Buccal drug delivery systemshardik dhiman
 
Buccal drug delivery systems
Buccal drug delivery systemsBuccal drug delivery systems
Buccal drug delivery systemshardik dhiman
 
Ocular bioavailability
Ocular bioavailabilityOcular bioavailability
Ocular bioavailabilitysneha chavan
 
Controlled release oral drug delivery
Controlled release oral drug deliveryControlled release oral drug delivery
Controlled release oral drug deliveryGaurav Kr
 
ocular barriers and methods to overcome barriers
ocular barriers and methods to overcome barriersocular barriers and methods to overcome barriers
ocular barriers and methods to overcome barriersTarun Gollapudi
 
mucoadhesive drug delivery system.pptx
mucoadhesive drug delivery system.pptxmucoadhesive drug delivery system.pptx
mucoadhesive drug delivery system.pptxRevathykrishnan13
 
Ocular drug delivery systems
Ocular drug delivery systemsOcular drug delivery systems
Ocular drug delivery systemsSnehaPachore
 
Orodispersible liquisolid compacts
Orodispersible liquisolid compactsOrodispersible liquisolid compacts
Orodispersible liquisolid compactsPranali Palandurkar
 
Formulation and evaluation of rosiglitazone nanosuspension
Formulation and evaluation of rosiglitazone nanosuspensionFormulation and evaluation of rosiglitazone nanosuspension
Formulation and evaluation of rosiglitazone nanosuspensionSriramNagarajan19
 
Jaideep Sarkar- Buccomucosal Drug Delivery System
Jaideep Sarkar- Buccomucosal Drug Delivery SystemJaideep Sarkar- Buccomucosal Drug Delivery System
Jaideep Sarkar- Buccomucosal Drug Delivery SystemGlaxoSmithKline Pharma GmbH
 
ocular drug delivery
ocular drug deliveryocular drug delivery
ocular drug deliveryJayeshRajput7
 
Unit III_Transdermal DDS.pdf
Unit III_Transdermal DDS.pdfUnit III_Transdermal DDS.pdf
Unit III_Transdermal DDS.pdfbijaybhattarai942
 
Mechanism of dds1
Mechanism of dds1Mechanism of dds1
Mechanism of dds1Sachin G
 
Drug Absorption(Ver 20.0).pptx
Drug Absorption(Ver 20.0).pptxDrug Absorption(Ver 20.0).pptx
Drug Absorption(Ver 20.0).pptxChangbaeg Lim
 

Ähnlich wie Bioavailability Of Disperse Dosage Form (20)

Diffusion finals, feb 29, 2012
Diffusion finals, feb 29, 2012Diffusion finals, feb 29, 2012
Diffusion finals, feb 29, 2012
 
Ndds
NddsNdds
Ndds
 
Buccal drug delivery systems
Buccal drug delivery systemsBuccal drug delivery systems
Buccal drug delivery systems
 
Buccal drug delivery systems
Buccal drug delivery systemsBuccal drug delivery systems
Buccal drug delivery systems
 
Ocular bioavailability
Ocular bioavailabilityOcular bioavailability
Ocular bioavailability
 
Controlled release oral drug delivery
Controlled release oral drug deliveryControlled release oral drug delivery
Controlled release oral drug delivery
 
ocular barriers and methods to overcome barriers
ocular barriers and methods to overcome barriersocular barriers and methods to overcome barriers
ocular barriers and methods to overcome barriers
 
mucoadhesive drug delivery system.pptx
mucoadhesive drug delivery system.pptxmucoadhesive drug delivery system.pptx
mucoadhesive drug delivery system.pptx
 
Ocular drug delivery systems
Ocular drug delivery systemsOcular drug delivery systems
Ocular drug delivery systems
 
Orodispersible liquisolid compacts
Orodispersible liquisolid compactsOrodispersible liquisolid compacts
Orodispersible liquisolid compacts
 
Formulation and evaluation of rosiglitazone nanosuspension
Formulation and evaluation of rosiglitazone nanosuspensionFormulation and evaluation of rosiglitazone nanosuspension
Formulation and evaluation of rosiglitazone nanosuspension
 
Jaideep Sarkar- Buccomucosal Drug Delivery System
Jaideep Sarkar- Buccomucosal Drug Delivery SystemJaideep Sarkar- Buccomucosal Drug Delivery System
Jaideep Sarkar- Buccomucosal Drug Delivery System
 
Lec 4 & 5
Lec 4 & 5Lec 4 & 5
Lec 4 & 5
 
General pharmacology
General pharmacologyGeneral pharmacology
General pharmacology
 
Dissolution
DissolutionDissolution
Dissolution
 
ocular drug delivery
ocular drug deliveryocular drug delivery
ocular drug delivery
 
Ocular Drug Delivery System.pptx
Ocular Drug Delivery System.pptxOcular Drug Delivery System.pptx
Ocular Drug Delivery System.pptx
 
Unit III_Transdermal DDS.pdf
Unit III_Transdermal DDS.pdfUnit III_Transdermal DDS.pdf
Unit III_Transdermal DDS.pdf
 
Mechanism of dds1
Mechanism of dds1Mechanism of dds1
Mechanism of dds1
 
Drug Absorption(Ver 20.0).pptx
Drug Absorption(Ver 20.0).pptxDrug Absorption(Ver 20.0).pptx
Drug Absorption(Ver 20.0).pptx
 

Kürzlich hochgeladen

Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformChameera Dedduwage
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationnomboosow
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Celine George
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docxPoojaSen20
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Disha Kariya
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesFatimaKhan178732
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
social pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajansocial pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajanpragatimahajan3
 
The byproduct of sericulture in different industries.pptx
The byproduct of sericulture in different industries.pptxThe byproduct of sericulture in different industries.pptx
The byproduct of sericulture in different industries.pptxShobhayan Kirtania
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdfSoniaTolstoy
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptxVS Mahajan Coaching Centre
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfciinovamais
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDThiyagu K
 

Kürzlich hochgeladen (20)

Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy Reform
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communication
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docx
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and Actinides
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
social pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajansocial pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajan
 
The byproduct of sericulture in different industries.pptx
The byproduct of sericulture in different industries.pptxThe byproduct of sericulture in different industries.pptx
The byproduct of sericulture in different industries.pptx
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
Advance Mobile Application Development class 07
Advance Mobile Application Development class 07Advance Mobile Application Development class 07
Advance Mobile Application Development class 07
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 

Bioavailability Of Disperse Dosage Form

  • 1. Bioavailability Of Disperse Dosage Forms By Mohammad Sohail Mphil pharmaceutics Islamia university Bahawalpur [email_address]
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8. AB vs RBA Drug Product AUC ( mcg/ml . hr ) A IV Injection 100 B Oral dosage form (Refer) 50 C Oral dosage form (generic) 40
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 24.
  • 25.
  • 27.
  • 28.
  • 30.
  • 31.
  • 32.
  • 33.
  • 34. Absorption Factors SKIN EYE GIT Barrier Stratum corneum Superficial layer of epithelium Epithelium Thickness 8-26 layers 5-6 layers 1 layer hydration 10-25% 78% High area 2-25cm 2 1.3cm 2 2,000,000
  • 35.
  • 36.
  • 37.
  • 38.
  • 39.
  • 40.
  • 41.
  • 42.
  • 43.
  • 44.
  • 45. pH Location pH Stomach Duodenum Jejunum Ileum Colon Rectum 1.5-3.5 5-7 6-7 6.0-7.5 5.5-7.0 7
  • 46.
  • 47.
  • 48.
  • 49.
  • 50.
  • 51.
  • 52.
  • 53.
  • 54.
  • 55.
  • 56.
  • 57.
  • 58.
  • 59.
  • 60. Plasma concentration vs. time profile of a single dose of a drug ingested orally Plasma Concentration
  • 61.
  • 62. AUC
  • 63.
  • 64.
  • 65.
  • 67.
  • 68.
  • 69. Acute pharmacodynamic or pharmacologic effect
  • 70.
  • 71.
  • 72.
  • 73.
  • 74.
  • 75.
  • 76.
  • 77.
  • 78.
  • 79.
  • 80.
  • 81.
  • 82.
  • 83.
  • 84.
  • 85.
  • 86.
  • 87.
  • 88.
  • 89.
  • 90.
  • 91.
  • 92.
  • 93.
  • 94.